Delivery Order SPE2DB22D3501-SPE2DB24FTW27

Award Date 12/14/23
Potential Completion Date 1/8/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 10 MG CAPSULE 100S. The order has a potential value of $158,419.32 and a completion date of February 5, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to support DLA Troop Support Medical facilities. The company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution services company. The award is for the supply of REVLIMID 15 MG CAPSULE 21S, a specialty pharmaceutical product, at a firm fixed price of $10,526.04. The completion date for this delivery order is February 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4564060034 REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $13,929.89 and a performance period through April 12, 2024. This delivery order is issued under Amerisourcebergen's pre-existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4557530338 - REVLIMID 5 MG CAPSULE 100S. The $160,303.95 firm fixed price delivery order contract has a completion date of July 5, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 10 MG CAPSULE 100S. The firm fixed price contract has a potential value of $106,870.16 and a completion date of June 16, 2022. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office location in Conshohocken, Pennsylvania. No set-aside...
The Defense Logistics Agency awarded a $28,245 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561632369 REVLIMID 10 MG CAPSULE 28S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 17, 2023 in support of the Defense Logistics Agency's medical supply chain programs. No subcontractors or set aside designations were identified in the award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,963.40 firm fixed-price delivery order is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on February 18, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product REVLIMID 10 MG CAPSULE 28S, with a ceiling value of $49,926.80 and a period of performance through August 2, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $106,732.90 firm fixed price order is for the supply of REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing pharmaceuticals, medical supplies, and distribution services to DLA...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTW27
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $28,245.26 to AmerisourceBergen Drug Corp, a wholly owned subsidiary of AmerisourceBergen Corporation, for the provision of REVLIMID 10 MG CAPSULE 28S. This delivery order contract has a performance period through January 8, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product from its corporate office location in Conshohocken, Pennsylvania. This award is not associated with any set-aside designations. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for providing a range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide.

Generated 5/3/24, 9:58 AM